Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Jeffrey Borgia and Christopher Seder.
Jeffrey Borgia
Connection Strength
1.581
Christopher Seder
  1. Conditional survival analysis of patients with resected non-small cell lung cancer. JTCVS Open. 2023 Dec; 16:948-959.
    View in: PubMed
    Score: 0.201
  2. Low-Dose Computed Tomography Scan Features Are Associated With Annual Risk of Hospitalization. Ann Thorac Surg Short Rep. 2023 Dec; 1(4):558-561.
    View in: PubMed
    Score: 0.199
  3. The association between thoracic sarcopenia and survival is gender specific in early-stage lung cancer. J Thorac Dis. 2022 Nov; 14(11):4256-4265.
    View in: PubMed
    Score: 0.189
  4. The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer. Oncotarget. 2022; 13:393-407.
    View in: PubMed
    Score: 0.180
  5. Sarcopenia after induction therapy is associated with reduced survival in patients undergoing esophagectomy for locally-advanced esophageal cancer. J Thorac Dis. 2021 Feb; 13(2):861-869.
    View in: PubMed
    Score: 0.168
  6. Circulating histocompatibility antigen (HLA) gene products may help differentiate benign from malignant indeterminate pulmonary lesions. Hum Immunol. 2018 Jul; 79(7):558-563.
    View in: PubMed
    Score: 0.138
  7. Circulating angiogenesis biomarkers are associated with disease progression in lung adenocarcinoma. Ann Thorac Surg. 2014 Dec; 98(6):1968-75; discussion 1975.
    View in: PubMed
    Score: 0.108
  8. Value of circulating insulin-like growth factor-associated proteins for the detection of stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2015 Mar; 149(3):727-34.e1-3; discussion 734.
    View in: PubMed
    Score: 0.108
  9. Association Between Rare Germline Variants in Cancer Susceptibility Genes and Lung Cancer Risk. Ann Thorac Surg. 2026 Jul 31.
    View in: PubMed
    Score: 0.061
  10. Microfluidic lung cancer models: Bridging clinical treatment strategies and tumor microenvironment recapitulation. APL Bioeng. 2025 Dec; 9(4):041505.
    View in: PubMed
    Score: 0.059
  11. A robust machine learning model based on ribosomal-subunit-derived piRNAs for diagnostic potential of nonsmall cell lung cancer across multicentre, large-scale of sequencing data. Clin Transl Med. 2025 08; 15(8):e70418.
    View in: PubMed
    Score: 0.057
  12. Circulating T-cell receptor repertoire for cancer early detection. NPJ Precis Oncol. 2025 Jul 19; 9(1):245.
    View in: PubMed
    Score: 0.057
  13. Exploratory Algorithms to Aid in Risk of Malignancy Prediction for Indeterminate Pulmonary Nodules. Cancers (Basel). 2025 Apr 05; 17(7).
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.